{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-096645","form_type":"8-K","ticker":"SABS","cik":"0001833214","company_name":"SAB Biotherapeutics, Inc.","filed_at":"2025-07-17T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.217329+00:00","generated_at":"2026-05-18T05:59:54.014592+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"confidence":"high","headline":"SAB Biotherapeutics elects four Class I directors, ratifies auditor at 2025 annual meeting","bullets":["Shareholders elected Dr. William Polvino, Scott Giberson, Erick Lucera, and Dr. Jay S. Skyler as Class I directors for three-year terms.","Appointment of EisnerAmper LLP as independent auditor for fiscal year 2025 ratified with 6,374,363 votes for, 238,327 against.","Quorum of 71.38% achieved; 6,633,125 shares present out of 9,291,697 outstanding.","Broker non-votes of 2,154,677 on director elections; each director received over 4.3 million votes for."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-096645","json":"https://secwatch.observer/filing/0000950170-25-096645.json","markdown":"https://secwatch.observer/filing/0000950170-25-096645.md","text":"https://secwatch.observer/filing/0000950170-25-096645.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1833214/000095017025096645/0000950170-25-096645-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1833214/000095017025096645/sabs-20250717.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T05:59:54.014592+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}